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Background: Brucella is a group of bacteria that causes brucellosis, which can affect population health and
reproductive success in many marine mammals. We investigated the serological prevalence of antibodies against
Brucella bacteria in a declining harbor seal population in Glacier Bay National Park, Alaska.
Results: Prevalence ranged from 16 to 74 percent for those tests detecting antibodies, indicating that harbor seals
in Glacier Bay have been exposed to Brucella bacteria. However, the actual level of serological prevalence could not
be determined because results were strongly assay-dependent.
Conclusions: This study reinforces the need to carefully consider assay choice when comparing different studies
on the prevalence of anti–Brucella antibodies in pinnipeds and further highlights the need for species- or
taxon-specific assay validation for both pathogen and host species.
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Harbor seal (Phoca vitulina) populations serve many im-
portant biological and sociocultural functions in Alaska.
Harbor seals are apex predators and serve as an import-
ant prey for species such as killer whales (Orcinus orca)
and Steller sea lions (Eumetopias jubatus) [1-3]. Harbor
seals are also important subsistence food for many local
communities, and play a prominent role in the culture
of the Huna-Tlingit and other tribes. Glacier Bay
National Park (GBNP) supports a unique stock of harbor
seals in Alaska [4] and historically was the location of
the largest breeding population of seals in the state. Yet
the population has been declining since 1992 [5] even
though foraging and other conditions have supported
significant increases in other marine mammals, such as
Steller sea lions and humpback whales, that utilize the
park during the summer [6,7]. Hypotheses for the causal
factors driving the decline include anthropogenic dis-
turbance, although a recent study demonstrated that dis-
turbance is not likely to be sufficiently frequent to* Correspondence: khueffer@alaska.edu
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reproduction in any medium, provided the orinfluence population dynamics [8]. Large populations of
forage fish persist in GBNP [9], making food availability
unlikely as a possible explanation for the population de-
cline, and seals that breed in Glacier Bay are of similar
physiological condition as those in other stable or in-
creasing populations [10]. Predation by the increasing
population of Steller sea lions has also been proposed al-
though this is not likely to be the sole factor driving
population dynamics [3]. Together then a number of hy-
potheses (food availability, disturbance, predation) have
been addressed with no significant evidence identifying
the cause for the observed decline in this population.
Here we perform a serological survey for exposure to
Brucella bacteria, pathogens of concern in marine
mammals in Alaska. In a recent study we determined
the prevalence of antibodies against Leptospira spp.,
Toxoplasma gondii and distemper viruses as well as
presence of Giardia and Cryptosporidium in fecal sam-
ples from this population [11] but we did not investigate
the presence of Brucella bacteria, which are known to be
present in harbor seals in Southeast Alaska [12]. Brucella
bacteria have been identified as pathogens in marine
mammals since 1994 [13] and have since been isolated, or
anti–Brucella antibodies have been detected, in multipleLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Brucellosis is a bacterial infection that can affect repro-
ductive organs and therefore influence fecundity and lead
to reduced recruitment and alter population dynamics
[15], although in pinnipeds overt pathological findings
have so far not been observed [14]. In addition, marine-
derived Brucella bacteria have significant zoonotic poten-
tial in people exposed to marine mammals [16-18].
In this study we tested serum samples described previ-
ously [11] for anti–Brucella antibodies using six different
tests in order to gain insight into the serological preva-
lence to assess the possible exposure to Brucella bacteria
in Glacier Bay harbor seals.Methods
Samples
In order to determine if the harbor seal population in
GBNP had been exposed to Brucella bacteria we performed
a number of serological tests to detect anti–Brucella
antibodies in seals captured in 2007 (49 animals) and 2008
(44 animals) from harbor seals in Johns Hopkins Inlet
(58.84N 137.11W), Glacier Bay National Park (GBNP),
Alaska as described previously [11]. Age classes were
determined [19], and 46 animals were classified as pups,
19 as yearlings, 10 as subadults, and 18 as adults. 51
animals were female and 42 were male.
All animal sampling was in accordance with approval
of Institutional Animal Care and Use Committees at the
University of Alaska Fairbanks (protocol 07–37) and the
State of Alaska Department of Fish and Game (protocol
07–16), as well as a permit from the National Oceano-
graphic and Atmospheric Administration under the
Marine Mammal Protection Act (Permit 358-1787-00).Serological tests
Brucellosis card test
Brucellosis Card tests (Becton Dickinson, Cockeysville,
MD, US) using B. abortus strain 1119–3 as the antigen
was performed independently according to manufac-
turer’s instructions at the University of Alaska Fairbanks
and the diagnostic laboratory of Colorado State Univer-
sity to ensure consistency between operators.B. abortus plate test
Harbor seal serum was pipetted onto etched glass plates.
Standard B. abortus Standard Plate Antigen (Strain
1119–3, National Veterinary Services Laboratories,
Ames, Iowa, US) was added and thoroughly mixed with
the serum and the plate rotated and incubated for 8
minutes further rotated before agglutination was
assessed in indirect light over a black background.Competitive ELISA
Competitive ELISA was performed at Mystic Aquarium.
This test uses an antigen derived from Brucella isolated
from a harbor seal. Serum samples were tested at a 1:10
dilution and less than 25% inhibition was considered
negative. 25–29.9% inhibition was classified as a suspect
test and sera showing 30% or higher inhibition were
classified as positive for antibodies to “marine” Brucella
spp. [20].
B. ovis ELISA as well as B. canis RSAT
B. ovis ELISA as well as B. canis RSAT were performed
at the diagnostic laboratory of Colorado State University.
The B. ovis ELISA followed the NVSL SeroPro protocol
using the REO198 Antigen. The B. canis RSAT test
utilized a commercially available test kit (D-TECW,
Synbiotics, Kansas City, MO).
Statistical analysis
The 95% confidence intervals for serological prevalence
were calculated as previously described [21]. The differ-
ent tests were compared by calculating positive percent-
age agreement, negative percent agreement and the
overall percent agreement as well as McNemar’s chi
square test for pair-wise comparison of the diagnostic
assays used in this study.
Results
Using an ELISA assay detecting B. ovis antibodies and a
rapid slide agglutination test (RSAT) detecting B. canis
antibodies, we did not detect an antibody positive sam-
ple in 93 animals tested. A Plate test for anti–Brucella
antibodies yielded a 74% (95% CI = 64-82%) serological
prevalence rate. The commercially available card test
used detected antibodies against B. abortus in 17% (95%
CI = 10-26%) and 16% (95% CI = 9-25%) samples for
UAF and CSU, respectively. To confirm these results we
performed this test independently and obtained very
similar results with 95% overall agreement. The com-
petitive ELISA based on a marine Brucella isolate
detected antibodies in 37% (95% CI = 27-47%) (Figure 1).
Using a McNemar’s Chi square test, the correlation
between the different assays showed great differences be-
tween results with the plate test having the greatest rate
of positive reactions. All tests for anti–Brucella antibody
showed significant differences (P < 0.001) in pair-wise
comparisons, except the card test done at CSU com-
pared to the card test at UAF (Table 1).
Discussion
This study is an extension of a previous assessment of
exposure of infectious agents in this declining harbor
seal population of GBNP [11], our work on brucellosis
in polar bears [22] and moose (Alces alces) [23,24], and
Figure 1 Serological prevalence of anti–Brucella antibodies for different tests. The percentage of positive reaction is shown with a 95% upper
and lower confidence interval. Assays for antibodies towards B. ovis and B. canis did not detect antibodies in any samples (data not presented).
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[12,25]. In the previous GBNP study that used the same
serum samples as the present study, antibodies to
Leptospira ssp. were detected while anti-distemper anti-
bodies were not detected, potentially leaving the popula-
tion in Glacier Bay vulnerable to this severe viral disease
[11]. To assess if exposure to Brucella bacteria was evi-
dent and could be involved in the past and current
population decline in the Glacier Bay harbor seal popu-
lation, we tested serum from harbor seals from this area
for the presence of anti–Brucella antibodies. Based on
the uncertainty of Brucella species present in pinnipeds
in the North Pacific as well as assay dependent, cross re-
activity with other bacterial pathogens [26] we tested the
sera using six different assays. Serological prevalence
rates differed between assays detecting antibodies over a
range of 16 to 74 percent of samples. Two assays failed
to detect antibody, which was expected as B. ovis and B.
canis have not been described in harbor seals previously
and would likely not cross react with Brucella organism
(s) known to be circulating in harbor seal populations as
they have rough lipopolysaccharides (LPS), indicating
that the harbor seal most likely have been exposed to
Brucella species exhibiting a smooth phenotype. These
results indicate that Brucella bacteria are present in the
harbor seal population of Glacier Bay; however the actual
serological prevalence rate cannot be determined as differ-
ent assays gave widely varying results. Prevalence of anti–
Brucella antibodies ranged from 0 to 81 percent in other
studies [20,27-31] with variation attributed to annual
differences [30] and assay type [29]. Together, thesefindings highlight the need for cautious interpretation of
serological results of exposure to Brucella bacteria.
Comparing the results from diagnostic tests without
knowing the true prevalence of positive samples is diffi-
cult. No validated gold standard exists for the detection
of antibodies against Brucella in pinnipeds, and develop-
ing such a standard for all marine mammal species and
Brucella species is logistically difficult and cost prohibi-
tive [27]. Using total predictive agreement as a measure,
the plate test shows less than 55% agreement with the
other tests. The card test and the cELISA agreed reason-
ably well, with over 70% total predictive agreement
(Table 1). While this agreement is useful at a population
level, it is less useful for assessing the status of individual
animals. The apparent higher serological prevalence using
the plate test could be explained by the conversion of
fibrinogen to fibrin, which can lead to false positive results
[27]; cross reactivity with antibodies to other gram nega-
tive bacteria could be an alternative explanation. However,
the card test employed the same antigen and did not
result in such high prevalence rates, indicating that cross
reactivity of antibodies against other pathogens with the
antigen used in this assay is not the main reason for the
higher rate of positive samples when using the plate test.
Due to the assay dependence of serological prevalence
and the uncertain pathology of brucellosis in pinnipeds,
the influence of brucellosis on the harbor seal popula-
tion in GBNP cannot be established. Because the sero-
logical tests used in this study are designed to detect
past exposure, no conclusions can be drawn on current
infection status or if Brucella bacteria are causing
Table 1 Pair-wise comparison of results from different
serological tests
A UAF card neg UAF card pos Total
cELISA neg 57 1 58
cELISA pos 19 15 34
Total 76 16 92
NPA: 75 PPA: 93 TPA: 78
McNemar’s chi2: 14.45 p < 0.001
B UAF card neg UAF card pos Total
plate neg 24 0 24
plate pos 53 16 69
Total 77 16 93
NPA: 31 PPA: 100 TPA: 43
McNemar’s chi2: 51.01 p < 0.001
C UAF card neg UAF card pos Total
CSU card neg 75 3 78
CSU card pos 2 13 15
Total 77 16 93
NPA: 97 PPA: 81 TPA: 95
McNemar’s chi2: 0 p > 0.1
D plate neg plate pos Total
cELISA neg 20 38 58
cELISA pos 4 30 34
Total 24 68 92
NPA: 83 PPA: 44 TPA: 54
McNemar’s chi2: 25.93 p < 0.001
E plate neg plate pos Total
CSU card neg 23 55 78
CSU card pos 1 14 15
Total 24 69 93
NPA: 96 PPA: 20 TPA: 40
McNemar’s chi2: 50.16 p < 0.001
F cELISA neg cELISA pos Total
CSU card neg 55 22 77
CSU card pos 3 12 15
Total 58 34 92
NPA: 95 PPA: 35 TPA: 73
McNemar’s chi2: 12.96 p < 0.001
The results for two tests were compared for all samples to determine
relationship between results of different tests. Test agreement is represented
as negative (NPA), positive (PPA) and total (TPA) predictive agreement. Results
for the McNemar’s Chi2 test are represented as Chi2 and the corresponding p
value for 1 df. Assays for B. ovis and B. canis results are not included here.
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Brucellosis in the possible multifactorial population
decline cannot be excluded. In addition our results show
the presence of a zoonotic agent in this population,
which should be taken into consideration in any man-
agement and animal handling decisions.
The assay dependent differences in apparent exposure
rates to Brucella bacteria reinforce the need for a carefulapproach to comparing literature on exposure to Bru-
cella bacteria in pinnipeds using common diagnostic
approaches, which are often not developed for or vali-
dated in marine mammals. While biological factors, such
as age of animals sampled [12] are important in compar-
ing different studies on Brucella exposure prevalence in
pinnipeds, the serological test used should be considered
an additional and possibly the main source of variation.
Studies can only be compared and used to determine
trends if similar assays were used in previous studies
employing similar methods (including criteria to deem a
sample positive). As most commonly used tests for anti-
bodies against Brucella are based on methodology devel-
oped for livestock, companion animals, or humans, the
marine cELISA used in this study is likely the most ap-
propriate among the tests used here. In addition this test
has been validated in detecting antibodies in harbor seals
with brucellosis. It’s also a competitive ELISA and thus
increases the usefulness across different host taxa as re-
activity to antibodies of the host by secondary antibodies
is not necessary. However the possibility that different
biovars exist between B. pinnipedia and uncertainty
about Brucella spp. distribution in marine mammals
should lead to careful interpretation of even this assay,
which is based on a marine derived Brucella isolate. We
strongly suggest that if results from a study are intended
to be compared to previously conducted serosurveys in
pinnipeds that the same test from the historic study be
included alongside the marine based cELISA.Conclusions
In this study we show that the declining harbor seal
population in GBNP has been exposed to Brucella bac-
teria and that these pathogens could play a role in affect-
ing the health of this population. Prevalence of
antibodies against Brucella bacteria varied greatly be-
tween assays. Based on validation of this assay in harbor
seals described in the literature the marine based cELISA
is identified as the most appropriate test employed here.
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